Treatment of conditions requiring enhanced oxygen availability of mammalian tissues
US5015663A · kind A · utility
1Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 1990 |
| Grant date | May 14, 1991 |
| Priority date | — |
| Expiry date | Mar 5, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.